BeiGene (百济神州) Post-IPO: An ADR Tracker with Limited Near-Term Upside
BeiGene is the second biotech company to list in Hong Kong under amended listing rules that allow biotech companies which are yet to see a profit...
417 Views
Ascletis Pharma (歌礼制药) Post-Listing: Thoughts on Liquidity and Bull Cases
Ascletis Pharma, the first biotech companies to list in Hong Kong without a profit under the amended listing rules, debuted last week with poor...
399 Views
Last Week in GER Research: Ascletis Pharma, China Tower, Pinduoduo, Beigene and CNFinance
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight our sensitivity analysis for Ascletis...
810 Views
Smartkarma: ECM Coverage Weekly Update (4 August 2018)
The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. Ascletis Pharma Inc...
442 Views
Hope Education (希望教育) IPO Trading - Appears Fully Priced for Now
Hope Education Group Co Ltd (1765 HK) quickly broke its IPO price after opening at HK$1.92 a share. There had been warning signs from its gray...
559 Views